Who should receive HPV vaccine?
| MSM: Age groups (yrs) | Number (%) | Other groups | Number (%) |
|---|---|---|---|
| 12–26 | 41/119 (34%) | HIV positive 12–26 yrs | 36/123 (30%) |
| 12–40 | 16/119 (13%) | HIV positive All | 95/123 (78%) |
| 18–26 | 3/119 (3%) | Immunocompromised other | 87/123 (71%) |
| 18–40 | 10/119 (10%) | Current or past HPV disease | 32/123 (26%) |
| All | 49/119 (49%) | Screen for HPV types first | 1/123 (1%) |